Phage therapy: unexpected drawbacks to reach hospitals

This study was funded by grants AGL2015-65673-R (MINECO/FEDER/EU, Spain), EU ANIWHA ERA-NET (BLAAT ID: 67)/PCIN2017-001 (AEI/FEDER/EU, Spain), Proyecto Intramural CSIC 201770E016, IDI/2018/000119 (Asturias Innovation 2018–2020, Principado de Asturias, Spain) and FEDER/EU. P Garcia and A Rodriguez are members of the bacteriophage network FAGOMA and the FWO Vlaanderen funded ‘Phagebiotics’ research community (WO.016.14)